O'Reilly SM - Search Results

1

Early evaluation of tumour metabolic response using [18F]fluorodeoxyglucose and positron emission tomography: a pilot study following the phase II chemotherapy schedule for temozolomide in recurrent high-grade gliomas.

Brock CS, Young H, O'Reilly SM, Matthews J, Osman S, Evans H, Newlands ES, Price PM. Brock CS, et al. Br J Cancer. 2000 Feb;82(3):608-15. doi: 10.1054/bjoc.1999.0971. Br J Cancer. 2000. PMID: 10682673 Free PMC article. Clinical Trial.

2

The Charing Cross Hospital experience with temozolomide in patients with gliomas.

Newlands ES, O'Reilly SM, Glaser MG, Bower M, Evans H, Brock C, Brampton MH, Colquhoun I, Lewis P, Rice-Edwards JM, Illingworth RD, Richards PG. Newlands ES, et al. Eur J Cancer. 1996 Dec;32A(13):2236-41. doi: 10.1016/s0959-8049(96)00258-4. Eur J Cancer. 1996. PMID: 9038604 Clinical Trial.

3

Temozolomide: a new oral cytotoxic chemotherapeutic agent with promising activity against primary brain tumours.

O'Reilly SM, Newlands ES, Glaser MG, Brampton M, Rice-Edwards JM, Illingworth RD, Richards PG, Kennard C, Colquhoun IR, Lewis P, et al. O'Reilly SM, et al. Eur J Cancer. 1993;29A(7):940-2. doi: 10.1016/s0959-8049(05)80198-4. Eur J Cancer. 1993. PMID: 8499146 Clinical Trial.

4

A weekly alternating chemotherapy regimen with low toxicity for the treatment of aggressive lymphoma.

Bower M, Brock C, Gulliford T, O'Reilly SM, Smith DB, Newlands ES. Bower M, et al. Cancer Chemother Pharmacol. 1996;38(1):106-9. doi: 10.1007/s002800050455. Cancer Chemother Pharmacol. 1996. PMID: 8603443 Clinical Trial.

5

Sources of error in tissue and tumor measurements of 5-[18F]fluorouracil.

Harte RJ, Matthews JC, O'Reilly SM, Price PM. Harte RJ, et al. J Nucl Med. 1998 Aug;39(8):1370-6. J Nucl Med. 1998. PMID: 9708510 Free article.

6

Tumor, normal tissue, and plasma pharmacokinetic studies of fluorouracil biomodulation with N-phosphonacetyl-L-aspartate, folinic acid, and interferon alfa.

Harte RJ, Matthews JC, O'Reilly SM, Tilsley DW, Osman S, Brown G, Luthra SJ, Brady F, Jones T, Price PM. Harte RJ, et al. J Clin Oncol. 1999 May;17(5):1580-8. doi: 10.1200/JCO.1999.17.5.1580. J Clin Oncol. 1999. PMID: 10334547

7

Current approaches to diagnosis and treatment of gestational trophoblastic disease.

Smith DB, O'Reilly SM, Newlands ES. Smith DB, et al. Curr Opin Obstet Gynecol. 1993 Feb;5(1):84-91. Curr Opin Obstet Gynecol. 1993. PMID: 8381037 Review.

8

Single agent activity of carboplatin in patients with previously untreated non-seminomatous germ cell tumours.

O'Reilly SM, Rustin GJ, Smith DB, Newlands ES. O'Reilly SM, et al. Ann Oncol. 1992 Feb;3(2):163-4. doi: 10.1093/oxfordjournals.annonc.a058134. Ann Oncol. 1992. PMID: 1376619 Free article. Clinical Trial.

9

Weekly cisplatinum concomitant with radical radiotherapy in the treatment of advanced head and neck cancer.

Glaser MG, Leslie MD, O'Reilly SM, Cheesman AD, Newlands ES. Glaser MG, et al. Clin Oncol (R Coll Radiol). 1993;5(5):286-9. doi: 10.1016/s0936-6555(05)80902-1. Clin Oncol (R Coll Radiol). 1993. PMID: 8305336 Clinical Trial.

10

Dose intensification in the treatment of patients with testicular germ cell tumours.

O'Reilly SM, Smith DB, Newlands ES, Rustin GJ. O'Reilly SM, et al. Eur J Cancer. 1994;30A(5):723. doi: 10.1016/0959-8049(94)90561-4. Eur J Cancer. 1994. PMID: 7521654 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

63 results

Search Page

Filters